A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions

Sean Chia, Rodrigo Cataldi, Francesco Simone Ruggeri, Ryan Limbocker, Itzel Condado Morales, Katarina Pisani, Andrea Possenti, Sara Linse, Tuomas P. J. Knowles, Johnny Habchi, Benedetta Mannini, Michele VendruscoloACS 2024 · DOI

TL;DR

This study reveals that different metal ions can stabilize distinct forms of amyloid-beta (Aβ) oligomers, each with unique structural properties and varying levels of neurotoxicity. Crucially, the research establishes a direct correlation between the size of these Aβ oligomers and their ability to damage neuronal cells, suggesting size is a key determinant of toxicity in Alzheimer's disease.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by the accumulation of misfolded proteins, particularly amyloid-beta (Aβ) peptides, in the brain. While Aβ plaques are a hallmark, growing evidence points to smaller, soluble Aβ oligomers as the primary culprits behind neuronal dysfunction and cell death. However, Aβ oligomers are notoriously heterogeneous and transient, making it challenging to pinpoint which specific structural features drive their neurotoxicity. This paper tackles this complexity by investigating how different metal ions, known to be present in the brain and implicated in AD pathology, influence the formation and properties of Aβ oligomers, and how these variations in structure relate to their toxic effects on neurons.

Methods

The researchers employed a multi-pronged approach to characterize the Aβ oligomers and their effects:

  • Oligomer Preparation: Aβ40 peptides were incubated with four different metal ions (Zn<sup>2+</sup>, Cu<sup>2+</sup>, Al<sup>3+</sup>, and Fe<sup>2+</sup>) under specific conditions to generate kinetically stable oligomeric species.
  • Morphological and Size Analysis: Atomic Force Microscopy (AFM) was used to visualize the physical structure and measure the height (size) of the oligomers. Static Light Scattering (SLS) and Turbidity measurements provided complementary bulk measurements of aggregate size.
  • Structural Characterization:
    • Hydrophobicity: The fluorescent probe 8-anilinonaphthalene-1-sulfonate (ANS) was used to assess the exposure of hydrophobic surfaces on the oligomers.
  • Secondary Structure: Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) spectroscopy was employed to determine the presence and type of secondary structures (e.g., β-sheets).
  • β-sheet Content: Thioflavin T (ThT) fluorescence was used to quantify the extent of β-sheet structure, as ThT binds strongly to these structures.
  • Cellular Toxicity Assays: Human neuroblastoma cells (SH-SY5Y) were treated with the different Aβ oligomers to assess:
  • Cell Viability: MTT assay to measure mitochondrial activity, indicating cell health.
  • Reactive Oxygen Species (ROS) Production: Assessed using a fluorometric kit to quantify oxidative stress.
  • Calcium (Ca<sup>2+</sup>) Influx: Measured using a fluorescent dye to detect membrane permeabilization.
  • Correlation Analysis: Regression analysis was performed to correlate the measured structural properties (hydrophobicity, β-sheet content, size) with the observed cellular toxicity markers.

Datasets

Not discussed in the paper. The study utilizes synthesized Aβ40 peptides and metal ions, and human neuroblastoma cells as the biological system for toxicity testing.

Key Insights and Ideas

  • Metal Ions as Oligomer Sculptors: Different metal ions don't just interact with Aβ; they actively shape the resulting oligomers, leading to distinct sizes and structural characteristics. This highlights the crucial role of the cellular environment in dictating Aβ aggregation pathways.
  • Size Matters Most for Toxicity: While hydrophobicity and β-sheet content were measured, the study found that the size of the Aβ oligomers was the most significant predictor of their neurotoxic potential. Smaller oligomers were consistently more damaging.
  • Aβ-FeO Oligomers: The "Quiet" Ones: Interestingly, Aβ-FeO oligomers, despite being larger, showed significantly less toxicity across all tested assays (viability, ROS, Ca<sup>2+</sup> influx). This suggests that larger size might confer a protective effect or that these specific oligomers have a fundamentally different, less disruptive mechanism of action.
  • Implications for AD Therapeutics: The findings underscore the challenge for therapeutic strategies targeting Aβ. Simply aiming to reduce overall Aβ levels might not be sufficient if smaller, more toxic oligomers are still being formed. Therapies might need to specifically target the formation or clearance of these smaller species.

Key Results

  • Oligomer Size Variation: AFM revealed distinct size distributions for Aβ oligomers stabilized by different metal ions, with Aβ-ZnO and Aβ-CuO being smaller (2-2.5 nm) and Aβ-AlO and Aβ-FeO being larger (4-5 nm).
  • Structural Similarities and Differences: All oligomers exhibited parallel and antiparallel β-sheet structures, but differences in hydrophobicity and ThT fluorescence indicated variations in surface properties.
  • Differential Cytotoxicity:
    • Aβ-ZnO and Aβ-CuO significantly reduced cell viability, increased ROS production, and induced Ca<sup>2+</sup> influx.
  • Aβ-AlO induced Ca<sup>2+</sup> influx and reduced cell viability but showed less ROS production.
  • Aβ-FeO showed minimal cytotoxic effects across all assays.
  • Strong Size-Toxicity Correlation: Regression analysis showed a strong negative correlation between oligomer size and cell viability loss (R<sup>2</sup> = 0.94) and Ca<sup>2+</sup> influx (R<sup>2</sup> = 0.70). Smaller oligomers were more toxic.

Limitations and Future Work

  • In Vitro Model: The study uses human neuroblastoma cells (SH-SY5Y) as a model system. While informative, these cells may not fully recapitulate the complex environment and cell types found in the human brain. Future work could involve testing these oligomers in more complex neuronal cultures or animal models.
  • Metal Ion Stoichiometry: While a 1:10 protein:metal ion ratio was used for oligomer preparation, the paper notes that different molar equivalents of metal ions are required to inhibit Aβ aggregation, suggesting a complex dose-dependent interaction. Further exploration of these dose-response relationships could be valuable.
  • Mechanism of Aβ-FeO's Reduced Toxicity: The paper highlights that Aβ-FeO oligomers are less toxic despite being larger. The precise structural or mechanistic reasons for this reduced toxicity warrant further investigation.
  • Therapeutic Targeting: The authors suggest that future therapeutic strategies should consider the diversity of Aβ oligomers and their specific structural features, rather than a one-size-fits-all approach. Understanding the precise ion-Aβ interactions and their role in oligomer formation could lead to more targeted interventions.

Summary updated

Abstract

Oligomeric assemblies of the amyloid β peptide (Aβ) have been investigated for over two decades as possible neurotoxic agents in Alzheimer's disease. However, due to their heterogeneous and transient nature, it is not yet fully established which of the structural features of these oligomers may generate cellular damage. Here, we study distinct oligomer species formed by Aβ40 (the 40-residue form of Aβ) in the presence of four different metal ions (Al<sup>3+</sup>, Cu<sup>2+</sup>, Fe<sup>2+</sup>, and Zn<sup>2+</sup>) and show that they differ in their structure and toxicity in human neuroblastoma cells. We then describe a correlation between the size of the oligomers and their neurotoxic activity, which provides a type of structure-toxicity relationship for these Aβ40 oligomer species. These results provide insight into the possible role of metal ions in Alzheimer's disease by the stabilization of Aβ oligomers.
BibTeX
@inproceedings{chia2024relationship,
  author = {Sean Chia and Rodrigo Cataldi and Francesco Simone Ruggeri and Ryan Limbocker and Itzel Condado Morales and Katarina Pisani and Andrea Possenti and Sara Linse and Tuomas P. J. Knowles and Johnny Habchi and Benedetta Mannini and Michele Vendruscolo},
  title = {{A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions}},
  booktitle = {ACS},
  year = {2024},
  doi = {10.1021/acschemneuro.3c00718},
}
Figure